REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 307 filers reported holding REPLIGEN CORP in Q4 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,463,497 | +11.0% | 160,138 | -1.3% | 0.03% | +15.4% |
Q2 2023 | $22,940,568 | +85861.6% | 162,170 | +2.3% | 0.03% | -21.2% |
Q1 2023 | $26,687 | +1.7% | 158,510 | +2.3% | 0.03% | -5.7% |
Q4 2022 | $26,229 | -99.9% | 154,917 | +2.2% | 0.04% | -16.7% |
Q3 2022 | $28,354,000 | +17.6% | 151,537 | +2.1% | 0.04% | +20.0% |
Q2 2022 | $24,115,000 | -7.7% | 148,492 | +7.0% | 0.04% | +2.9% |
Q1 2022 | $26,113,000 | -29.1% | 138,830 | -0.2% | 0.03% | -24.4% |
Q4 2021 | $36,856,000 | -5.8% | 139,162 | +2.8% | 0.04% | -15.1% |
Q3 2021 | $39,121,000 | +43.9% | 135,370 | -0.6% | 0.05% | +47.2% |
Q2 2021 | $27,179,000 | +1.0% | 136,154 | -1.6% | 0.04% | -2.7% |
Q1 2021 | $26,901,000 | +1.3% | 138,375 | -0.1% | 0.04% | 0.0% |
Q4 2020 | $26,554,000 | +29.1% | 138,570 | -0.6% | 0.04% | +15.6% |
Q3 2020 | $20,573,000 | +18.1% | 139,439 | -1.0% | 0.03% | +10.3% |
Q2 2020 | $17,413,000 | +16.3% | 140,871 | -9.1% | 0.03% | -6.5% |
Q1 2020 | $14,967,000 | +2.6% | 155,035 | -1.7% | 0.03% | +29.2% |
Q4 2019 | $14,582,000 | +24.1% | 157,648 | +2.9% | 0.02% | +14.3% |
Q3 2019 | $11,749,000 | +0.0% | 153,202 | +12.1% | 0.02% | -4.5% |
Q2 2019 | $11,747,000 | +53.6% | 136,671 | +5.6% | 0.02% | +46.7% |
Q1 2019 | $7,650,000 | +13.0% | 129,477 | +0.9% | 0.02% | 0.0% |
Q4 2018 | $6,767,000 | +10.8% | 128,308 | +16.5% | 0.02% | +25.0% |
Q3 2018 | $6,110,000 | +17.8% | 110,176 | -0.1% | 0.01% | +20.0% |
Q2 2018 | $5,186,000 | +35.8% | 110,250 | +4.4% | 0.01% | +25.0% |
Q1 2018 | $3,820,000 | +2.5% | 105,594 | +2.8% | 0.01% | 0.0% |
Q4 2017 | $3,727,000 | +9.1% | 102,734 | +15.3% | 0.01% | +14.3% |
Q3 2017 | $3,415,000 | -1.6% | 89,120 | +6.4% | 0.01% | -12.5% |
Q2 2017 | $3,472,000 | +17.5% | 83,783 | -0.2% | 0.01% | +14.3% |
Q1 2017 | $2,956,000 | +47.7% | 83,987 | +29.3% | 0.01% | +40.0% |
Q4 2016 | $2,001,000 | +5.5% | 64,941 | +3.4% | 0.01% | 0.0% |
Q3 2016 | $1,896,000 | +15.0% | 62,801 | +4.2% | 0.01% | 0.0% |
Q2 2016 | $1,649,000 | +5.4% | 60,271 | +3.3% | 0.01% | 0.0% |
Q1 2016 | $1,565,000 | -4.0% | 58,339 | +1.2% | 0.01% | 0.0% |
Q4 2015 | $1,630,000 | +11.2% | 57,619 | +9.4% | 0.01% | 0.0% |
Q3 2015 | $1,466,000 | -30.6% | 52,649 | +2.9% | 0.01% | -28.6% |
Q2 2015 | $2,111,000 | +32.4% | 51,146 | -2.6% | 0.01% | +40.0% |
Q1 2015 | $1,595,000 | +69.5% | 52,521 | +10.5% | 0.01% | +66.7% |
Q4 2014 | $941,000 | -2.0% | 47,546 | -1.3% | 0.00% | 0.0% |
Q3 2014 | $960,000 | -12.7% | 48,196 | -0.2% | 0.00% | 0.0% |
Q2 2014 | $1,100,000 | +93.0% | 48,271 | +8.8% | 0.00% | +50.0% |
Q1 2014 | $570,000 | -8.9% | 44,353 | -3.3% | 0.00% | 0.0% |
Q4 2013 | $626,000 | +26.2% | 45,883 | +2.7% | 0.00% | 0.0% |
Q3 2013 | $496,000 | +112.9% | 44,683 | +58.0% | 0.00% | +100.0% |
Q2 2013 | $233,000 | – | 28,288 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |